Cassava's Alzheimer's drug fails in late-stage study-March 2024-www.financetom.com

Cassava's Alzheimer's drug fails in late-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Cassava's Alzheimer's drug fails in late-stage study

Nov 25, 2024 5:02 AM

Nov 25 (Reuters) - Cassava Sciences ( SAVA ) on Monday

said its experimental Alzheimer's disease drug did not meet the

main or secondary goals in a late-stage study.

Previous page： Bain Capital Specialty Finance Earnings Rise, Total Investment Income Falls in Q1; Declares Dividends Next page： Duke Energy beats first-quarter profit estimates on higher rates

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Bain Capital Specialty Finance Earnings Rise, Total Investment Income Falls in Q1; Declares Dividends

May 7, 2024

06:58 AM EDT, 05/07/2024 (MT Newswires) -- Bain Capital Specialty Finance ( BCSF ) reported Q1 earnings Monday of $0.53 per share, up from $0.50 a year earlier. Analysts polled by Capital IQ expected $0.55. Total investment income for the quarter ended March 31 was $74.5 million, down from $74.7 million a year earlier. Analysts surveyed by Capital IQ expected...

Duke Energy beats first-quarter profit estimates on higher rates

May 7, 2024

(Reuters) - Duke Energy ( DUK ) beat Wall Street estimates for first-quarter profit on Tuesday, as the utility benefited from higher rates and robust demand for electricity. Income from Duke's electric utilities segment jumped 29% to $1.02 billion. We have a clear path forward that will deliver sustainable value and 5% to 7% earnings growth over the next five...

Duke Energy Adjusted Earnings, Revenue Rise in Q1; Reaffirms Adjusted EPS for 2024

May 7, 2024

06:51 AM EDT, 05/07/2024 (MT Newswires) -- Duke Energy ( DUK ) reported Q1 earnings Tuesday of $1.44, up from $1.20 a year earlier. Analysts polled by Capital IQ expected $1.38. Total operating revenue for the quarter ended March 31 was $7.67 billion, up from $7.28 billion a year earlier. Analysts surveyed by Capital IQ expected $7.29 billion. The company...

Walt Disney Fiscal Q2 Adjusted Earnings, Revenue Rise

May 7, 2024

06:50 AM EDT, 05/07/2024 (MT Newswires) -- Walt Disney ( DIS ) reported fiscal Q2 adjusted earnings Tuesday of $1.21 per diluted share, up from $0.93 a year earlier. Analysts surveyed by Capital IQ expected $1.10. Revenue for the quarter ended March 31 was $22.08 billion, up from $21.82 billion a year earlier. Analysts polled by Capital IQ expected $22.14...